PROTACs improve selectivity for targeted proteins
www.scienceopen.com/hosted-docum...
#PROTAC #ProteinSelectivity #TargetedDegradation #DrugDesign #ChemicalBiology
Multi-specific antiviral PROTAC modality
www.scienceopen.com/hosted-docum...
#PROTAC #Antiviral #TargetedDegradation #DrugDiscovery #ChemicalBiology
PROTAC degraders recruiting MDM2
www.scienceopen.com/hosted-docum...
#PROTAC #MDM2 #E3Ligase #TargetedDegradation #DrugDesign
Computational strategies accelerating PROTAC discovery—driving next-generation targeted therapeutics
www.scienceopen.com/hosted-docum...
#PROTAC #DrugDiscovery #ComputationalChemistry #TargetedDegradation
Selinexor is an allosteric degrader. It stabilizes XPO1/CRM1 to expose a cryptic ASB8 E3 ligase site, triggering ubiquitination. Led by Casey Wing, Joyce Fung & Bert Kwanten. #TargetedDegradation #Allostery
Some of our recent work on models to design molecular glues, PROTACs (and really anything that forms a protein-protein complex) -- presented by Aram Davtyan at Keystone on Proximity-based Therapeutics this week!
#targetedDegradation #PROTAC #molecularGlue #drugDev #drugDesign #biotech #bioSky